Grant of Share Options to Directors
Summary by AI BETAClose X
Craneware plc
("Craneware" or the "Company")
Grant of Share Options to Directors
5 May 2026 - The Board of Craneware plc (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 5 May 2026, under the terms of the Craneware plc SAYE Option Plan (2018) ("the Option Plan"), share options (the "Options") to acquire ordinary shares of 1p each in the Company ("Shares") were granted to three Directors of the Company as follows:
|
Director |
Savings term |
No. of Shares over which Options granted under the Option Plan |
Percentage of issued share capital of the Company* |
|
Keith Neilson (CEO) |
3 years |
1,569 |
0.005% |
|
Craig Preston (CFO) |
3 years |
1,569 |
0.005% |
|
Isabel Urquhart (CPO) |
3 years |
784 |
0.002% |
*excluding 1,068,553 Shares held in treasury.
The Option Plan is a UK all employee HMRC approved Save As You Earn option scheme. The Options were granted on the same terms as other UK employees who chose to participate in the Option Plan. The Options have been granted at an exercise price of £11.594 per Share. The Options will ordinarily become exercisable for a period of six months from the end of the savings term.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and volume(s) Volume(s) granted 1,569, Price(s) £11.594
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 1,569
ii. Price(s) Price(s) £11.594
f) Date of the transaction 2026-05-05
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and volume(s) Volume(s) granted 1,569, Price(s) £11.594
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 1,569
ii. Price(s) Price(s) £11.594
f) Date of the transaction 2026-05-05
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
2. Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and volume(s) Volume(s) granted 784, Price(s) £11.594
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 784
ii. Price(s) Price(s) £11.594
f) Date of the transaction 2026-05-05
g) Place of the transaction Outside a trading venue
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal |
craneware@almastrategic.com |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Virginia Bull, Arnav Kapoor |
|
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Richard Andrews, Patrick Dolaghan |
|
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 19 minutes ago Schroder Income Growth Fund
- 21 minutes ago CVC Income & Growth Limited NPV GBP
- 24 minutes ago Schroder Japan Growth Fund
- 24 minutes ago SHAWBROOK GROUP PLC
- 25 minutes ago Schroder Japan Growth Fund